DE102012002209A1 - Biodegradierbares Vlies für medizinische Zwecke - Google Patents

Biodegradierbares Vlies für medizinische Zwecke Download PDF

Info

Publication number
DE102012002209A1
DE102012002209A1 DE102012002209A DE102012002209A DE102012002209A1 DE 102012002209 A1 DE102012002209 A1 DE 102012002209A1 DE 102012002209 A DE102012002209 A DE 102012002209A DE 102012002209 A DE102012002209 A DE 102012002209A DE 102012002209 A1 DE102012002209 A1 DE 102012002209A1
Authority
DE
Germany
Prior art keywords
biodegradable
nonwoven
fibers
water
fibrinolysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102012002209A
Other languages
German (de)
English (en)
Inventor
Dr. Vogt Sebastian
Dr. Copanaki Ekaterini
Dr. Grafahrend Dirk
Dr. Reibel Denis
Dr. Neumüller Dirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carl Freudenberg KG
Heraeus Medical GmbH
Original Assignee
Carl Freudenberg KG
Heraeus Medical GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carl Freudenberg KG, Heraeus Medical GmbH filed Critical Carl Freudenberg KG
Priority to DE102012002209A priority Critical patent/DE102012002209A1/de
Priority to PCT/EP2013/000198 priority patent/WO2013117298A1/de
Priority to ES13706167.7T priority patent/ES2644123T3/es
Priority to KR1020147025241A priority patent/KR101735899B1/ko
Priority to JP2014555118A priority patent/JP2015505490A/ja
Priority to CN201380008221.7A priority patent/CN104220101B/zh
Priority to RU2014136126/15A priority patent/RU2596502C2/ru
Priority to EP13706167.7A priority patent/EP2812037B1/de
Priority to AU2013218367A priority patent/AU2013218367B2/en
Priority to CA2862545A priority patent/CA2862545C/en
Priority to BR112014019436-0A priority patent/BR112014019436B1/pt
Priority to US14/375,460 priority patent/US20150010612A1/en
Publication of DE102012002209A1 publication Critical patent/DE102012002209A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0038—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/102—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/104—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • D—TEXTILES; PAPER
    • D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
    • D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
    • D01D10/00—Physical treatment of artificial filaments or the like during manufacture, i.e. during a continuous production process before the filaments have been collected
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Textile Engineering (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials For Medical Uses (AREA)
  • Artificial Filaments (AREA)
  • Nonwoven Fabrics (AREA)
DE102012002209A 2012-02-07 2012-02-07 Biodegradierbares Vlies für medizinische Zwecke Withdrawn DE102012002209A1 (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DE102012002209A DE102012002209A1 (de) 2012-02-07 2012-02-07 Biodegradierbares Vlies für medizinische Zwecke
PCT/EP2013/000198 WO2013117298A1 (de) 2012-02-07 2013-01-23 Biodegradierbares vlies für medizinische zwecke
ES13706167.7T ES2644123T3 (es) 2012-02-07 2013-01-23 Velo biodegradable para fines médicos
KR1020147025241A KR101735899B1 (ko) 2012-02-07 2013-01-23 의료용 생분해성 부직포 물질
JP2014555118A JP2015505490A (ja) 2012-02-07 2013-01-23 医療目的のための生分解性フリース
CN201380008221.7A CN104220101B (zh) 2012-02-07 2013-01-23 用于医疗用途的可生物降解的非织造织物及其制备方法
RU2014136126/15A RU2596502C2 (ru) 2012-02-07 2013-01-23 Биоразлагаемый нетканый материал для медицинских целей
EP13706167.7A EP2812037B1 (de) 2012-02-07 2013-01-23 Biodegradierbares vlies für medizinische zwecke
AU2013218367A AU2013218367B2 (en) 2012-02-07 2013-01-23 Biodegradable non-woven material for medical purposes
CA2862545A CA2862545C (en) 2012-02-07 2013-01-23 Biodegradable non-woven material for medical purposes
BR112014019436-0A BR112014019436B1 (pt) 2012-02-07 2013-01-23 Gaze biodegradável e método para produzir uma gaze biodegradável
US14/375,460 US20150010612A1 (en) 2012-02-07 2013-01-23 Biodegradable non-woven material for medical purposes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102012002209A DE102012002209A1 (de) 2012-02-07 2012-02-07 Biodegradierbares Vlies für medizinische Zwecke

Publications (1)

Publication Number Publication Date
DE102012002209A1 true DE102012002209A1 (de) 2013-08-08

Family

ID=47750605

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102012002209A Withdrawn DE102012002209A1 (de) 2012-02-07 2012-02-07 Biodegradierbares Vlies für medizinische Zwecke

Country Status (12)

Country Link
US (1) US20150010612A1 (cg-RX-API-DMAC7.html)
EP (1) EP2812037B1 (cg-RX-API-DMAC7.html)
JP (1) JP2015505490A (cg-RX-API-DMAC7.html)
KR (1) KR101735899B1 (cg-RX-API-DMAC7.html)
CN (1) CN104220101B (cg-RX-API-DMAC7.html)
AU (1) AU2013218367B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014019436B1 (cg-RX-API-DMAC7.html)
CA (1) CA2862545C (cg-RX-API-DMAC7.html)
DE (1) DE102012002209A1 (cg-RX-API-DMAC7.html)
ES (1) ES2644123T3 (cg-RX-API-DMAC7.html)
RU (1) RU2596502C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013117298A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102708805B1 (ko) 2015-11-08 2024-09-25 에디컨인코포레이티드 지혈 조성물
WO2021009013A1 (en) 2019-07-12 2021-01-21 Gatt Technologies B.V. Biocompatible, flexible, haemostatic sheet
ES2994191T3 (en) 2019-07-12 2025-01-20 Cilag Gmbh Haemostatic sheet
CN114096285A (zh) 2019-07-12 2022-02-25 加特技术公司 生物相容性柔性止血片
JP7555981B2 (ja) 2019-07-12 2024-09-25 ガット テクノロジーズ ビー.ブイ. 組織接着性シートを調製するための方法
GB2591088B (en) 2020-01-08 2024-07-03 Adv Med Solutions Ltd Antimicrobial fibres
US20230310698A1 (en) 2020-07-28 2023-10-05 Gatt Technologies B.V. Bone-adhesive sheet
JP7852824B2 (ja) 2021-01-08 2026-04-28 シラグ・ゲーエムベーハー・インターナショナル 生体吸収性封止粉末

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068149A2 (de) * 1981-06-25 1983-01-05 Serapharm GmbH & Co. KG Fibrinogen-haltiges Trockenpräparat, dessen Herstellung und Verwendung
EP0748633B1 (de) * 1995-06-12 2003-09-03 Baxter Aktiengesellschaft Gewebeklebstoff auf der Basis von Fibrinogen und Verwendung desselben zur Herstellung eines Hämostyptikum
DE69817594T2 (de) * 1997-09-19 2004-06-24 Baxter Ag Fibrinschwamm
DE102005048939A1 (de) 2005-07-01 2007-01-11 Carl Freudenberg Kg Vorrichtung, Anordnung und Verfahren zur Herstellung von Fasern und eine solche Fasern umfassende Anordnung
US20070255238A1 (en) * 1998-11-12 2007-11-01 Cochrum Kent C Hemostatic Polymer Useful for Rapid Blood Coagulation and Hemostasis
DE102007011606A1 (de) 2007-03-02 2008-09-04 Carl Freudenberg Kg Faser-Wirrgelege
DE102007044648A1 (de) 2007-09-18 2009-04-09 Carl Freudenberg Kg Bioresorbierbarer Gelatinevliesstoff
WO2011116848A2 (de) 2010-03-25 2011-09-29 Carl Freudenberg Kg Durch rotationsspinnverfahren hergestellte mehrkomponentenfasern

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5498091A (en) * 1978-01-18 1979-08-02 Unitika Ltd Wound protecting material
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
GB8419745D0 (en) * 1984-08-02 1984-09-05 Smith & Nephew Ass Wound dressing
ATE273035T1 (de) * 1993-11-03 2004-08-15 Clarion Pharmaceuticals Inc Hämostatisches pflaster
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
ATE316387T1 (de) * 2000-09-22 2006-02-15 Perlei Medical Produkte Gmbh Verwendung von antifibrinolytika für die präparation und herstellung von tupfern, kompressen oder pflaster
JP4464004B2 (ja) * 2001-02-28 2010-05-19 有限会社開発顧問室 医療用粘着シート
IS6390A (is) * 2001-08-31 2003-03-03 Heraeus Kulzer Gmbh & Co. Kg Reynsla af sýklalyfjahúðun skrokka sem í eru örholrými, þannig húðuðum skrokkum og einnig af notkunþeirra
EP1587424A4 (en) * 2002-12-31 2012-01-25 Marinepolymer Tech Inc Bleeding Compounds and their uses
GB2408330B (en) * 2003-11-22 2008-12-03 Advanced Gel Technology Ltd Polymeric materials comprising pH indicators for use in wound dressings
DE102004001594B4 (de) * 2004-01-09 2006-09-21 Bio-Gate Ag Wundauflage und Verfahren zu deren Herstellung
CN101001649B (zh) * 2004-07-09 2011-08-31 弗罗桑医疗设备公司 包括透明质酸的止血组合物及其制备方法
US8623842B2 (en) * 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
DE102007024220A1 (de) * 2007-05-15 2008-11-20 Aesculap Ag Blutstillendes Vlies
WO2009073854A1 (en) * 2007-12-06 2009-06-11 Nanosys, Inc. Resorbable nanoenhanced hemostatic structures and bandage materials
AU2009234203B2 (en) * 2008-04-11 2014-06-12 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Electrospun dextran fibers and devices formed therefrom
US10207022B2 (en) * 2009-09-01 2019-02-19 Medoderm Gmbh Chitosan tissue dressing
CN102905732A (zh) * 2010-03-15 2013-01-30 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的方法
EP2508212A1 (en) * 2011-04-05 2012-10-10 Universitätsklinikum Freiburg Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support
RU2013155713A (ru) * 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068149A2 (de) * 1981-06-25 1983-01-05 Serapharm GmbH & Co. KG Fibrinogen-haltiges Trockenpräparat, dessen Herstellung und Verwendung
EP0748633B1 (de) * 1995-06-12 2003-09-03 Baxter Aktiengesellschaft Gewebeklebstoff auf der Basis von Fibrinogen und Verwendung desselben zur Herstellung eines Hämostyptikum
DE69817594T2 (de) * 1997-09-19 2004-06-24 Baxter Ag Fibrinschwamm
US20070255238A1 (en) * 1998-11-12 2007-11-01 Cochrum Kent C Hemostatic Polymer Useful for Rapid Blood Coagulation and Hemostasis
DE102005048939A1 (de) 2005-07-01 2007-01-11 Carl Freudenberg Kg Vorrichtung, Anordnung und Verfahren zur Herstellung von Fasern und eine solche Fasern umfassende Anordnung
DE102007011606A1 (de) 2007-03-02 2008-09-04 Carl Freudenberg Kg Faser-Wirrgelege
DE102007044648A1 (de) 2007-09-18 2009-04-09 Carl Freudenberg Kg Bioresorbierbarer Gelatinevliesstoff
WO2011116848A2 (de) 2010-03-25 2011-09-29 Carl Freudenberg Kg Durch rotationsspinnverfahren hergestellte mehrkomponentenfasern

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
A. K. Lynn, I. V. Yannas, W. Bonfield; Antigenicity and immunogenicity of collagen; J Biomed Mater Res B Appl Biomater. 2004; 71(2); 343-354
H. E. Achneck, B. Sileshi, R. M. Jamiolkowski, D. A. Albala, M. L. Shapiro, J. H. Lawson; A comprehensive review of topical hemostatic agents: Efficacy and recommendations for use; Anals of Surgery. 2010; 251(2). 217-228
H. Seyedejad, M. Imani, T. Jamieson, A. M. Seifalian; Topical haemostatic agents; British Journal of Surgery; 2008; 95; 1197-1225
J. Dissemond; Die Bedeutung des pH-Wertes für die Wundheilung; HARTMANN wundForum 1/2006; 15-19)
K. Aktories, U. Förstermann, W. Forth; Allgemeine und spezielle Pharmakologie und Toxikologie; Elsevier, Urban&Fischer Verlag, 9. Auflage, 2006; 547
K. Tadokoro, T. Ohtoshi, S. Takafuiji, K. Nakajima, S. Suzuki, K. Yamamoto et al.; Topical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin-test studies; J Allergy Clin Immunol 1991; 88; 620-629
M. Pope, K. W. Johnston; Anaphylaxis after thrombin injection of a femoral pseudoaneurysm: recommendations for prevention; J Vasc Surg; 2000; 32; 190-191
R. N. Kaddoum, E. J. Chidiac, M. M. Zestos, S. D. Rajan, A. Baraka; An anaphylactic reaction alter primary exposure to an aprotinin test dose in a child with a severe milk allergy; J. Cardiothorac, Vase. Anesth.; 2007; 21; 243-244]
S. J. Eichhorn, W. W. Sampson, Statistical geometry of pores and statistics of porous nanofibrous assemblies, J. R. Soc. Interface, 2005; 2; 309-318
S. Srinath; Topical hemostatic agents in surgery: A surgeon's perspective; Aorn Journal. 2008; 88(3) 2-11]
W. Dietrich, A. Ebell, R. Busley, A. Boulesteix; Aprotinin and anaphylaxis: analysis of 12403 exposures to aprotinin in cardiac surgery; Ann. Thorac. Surg.; 2007; 84; 1144-1150
W. F. Konertz, M. Kostelka, F. W. Mohr et al.; Reducing the incidence and severity of pericardial adhesions with a sprayable polymeric matrix; Arm. Thorac. Surg.; 2003; 76; 1270-1274
Y. Tomizawa; Clinical benefits and risk analysis of topical hemostats: a review; J. Artif Organs. 2005; 8(3); 137-142
Y. Wai, V. Tsui, Z. Peng, R. Richardson, D. Oreopoulos, S. M. Tarlo; Anaphylaxis from topical bovine thrombin during haemodialysis and evaluation of sensitization among dialysis poulation; Clin Exp Allergy; 2003; 33; 1730-1734

Also Published As

Publication number Publication date
KR101735899B1 (ko) 2017-05-15
CA2862545C (en) 2016-07-12
US20150010612A1 (en) 2015-01-08
WO2013117298A1 (de) 2013-08-15
BR112014019436A2 (cg-RX-API-DMAC7.html) 2017-06-20
RU2596502C2 (ru) 2016-09-10
JP2015505490A (ja) 2015-02-23
AU2013218367B2 (en) 2015-07-09
ES2644123T3 (es) 2017-11-27
EP2812037B1 (de) 2017-08-09
AU2013218367A1 (en) 2014-09-04
CN104220101A (zh) 2014-12-17
CA2862545A1 (en) 2013-08-15
CN104220101B (zh) 2016-10-19
RU2014136126A (ru) 2016-03-27
KR20140121884A (ko) 2014-10-16
BR112014019436B1 (pt) 2019-05-21
BR112014019436A8 (pt) 2017-07-11
EP2812037A1 (de) 2014-12-17

Similar Documents

Publication Publication Date Title
EP2812037B1 (de) Biodegradierbares vlies für medizinische zwecke
EP0998949B1 (de) Flexible Wundauflage auf Fibrinbasis und Verfahren zu ihrer Herstellung
DE69231421T2 (de) Fibrin oder fibrinogen sowie biologisch abbaubare und biokompatible polymere enthaltende zusammensetzung zur gewebebehandlung
DE60009275T2 (de) Gefässtransplantat aus expandiertem polytetrafluorethylen mit einer beschichtung
DE69629010T2 (de) Selbsttragende flächengebilde aus vernetztem fibrin zur hemmung von postoperativen adhäsionen
DE69914451T2 (de) Zweischichtiges kollagenmaterial, dessen herstellungsprozess und therapeutische anwendung
DE69433939T2 (de) Hämostatisches pflaster
EP0092200B1 (de) Resorbierbares Flachmaterial zum Abdichten und Heilen von Wunden und Verfahren zu dessen Herstellung
DE69728054T2 (de) Bioresorbierbare dichtungsmassen für poröse künstliche gefässen
DE60203364T2 (de) Träger mit festem fibrinogen und thrombin
EP1615589B1 (de) Flächiges implantat
DE3788404T2 (de) Heparin enthaltendes Schutzmaterial zur Verhütung des Anhaftens und Verfahren.
DE3321446C2 (de) Verwendung von Chitosan zur Erzielung einer Hämostase, zur Inhibierung der Fibroplasie und zur Förderung der Geweberegeneration einer Wunde
DE69918714T2 (de) Herstellung von kollagenmaterial mit in vivo kontrollierter bioabbaubarkeit
DE69033243T2 (de) Verfahren zur Herstellung eines aus neutralisierter oxydierter Zelluloseproduktes und seine Verwendung
DE2515970A1 (de) Verdichteter filz
DE69431228T2 (de) Infektionsbeständige chirurgische Gegenstände und Verfahren zu deren Herstellung
WO2004091677A1 (de) Selbsthaftendes resorbierbares hämostyptikum
DE112017004570T5 (de) Wundabdeckung mit hämostatischer wirkung und verfahren zur herstellung einer solchen
EP1190724A1 (de) Verwendung von Antifibrinolytika für die Präparation und Herstellung von Tupfern, Kompressen oder Pflaster
DE69327793T2 (de) Absorbierbares topisches blutstillungsmittel
EP2098255B1 (de) Verfahren zur Herstellung von Kollagen-material
EP2147687B1 (de) Flächiges Implantat
EP2011523B1 (de) Blutstillendes Vlies
EP2815772A1 (de) Hämostyptikum

Legal Events

Date Code Title Description
R012 Request for examination validly filed
R016 Response to examination communication
R016 Response to examination communication
R083 Amendment of/additions to inventor(s)
R083 Amendment of/additions to inventor(s)
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee